Exabis Library
Welcome to the e-CCO Library!
DOP26 Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP26: Biological therapy increases NCR+ ILC3 levels in IBD patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP26: Biological therapy increases NCR+ ILC3 levels in IBD patients
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP26: Burden of perianal disease and perianal surgery in Crohn's disease over different therapeutic eras – a population-based study from western Hungary between 1977–2020, data from the Veszprem county cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP26: Burden of perianal disease and perianal surgery in Crohn’s disease over different therapeutic eras – a population-based study from western Hungary between 1977–2020, data from the Veszprem county cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP26: COVID-19 vaccine effectiveness in Inflammatory Bowel Disease patients on tumor-necrosis factor inhibitors: Real world data from a mass-vaccination campaign
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP26: Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohort
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP26: Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP26: Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP26: The relationship between vedolizumab therapeutic drug monitoring, biomarkers of inflammation, and clinical outcomes in Inflammatory Bowel Disease in the real-world setting
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP27 Transanal minimally invasive surgery (TAMIS): A novel approach for treatment of pouch failure
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP27: Disease activity patterns in the first 5 years after diagnosis in children with Crohn's disease: a population-based study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP27: Disease activity patterns in the first 5 years after diagnosis in children with Crohn’s disease: a population-based study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP27: Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP27: Sequencing-based hematopoietic miRNA landscape reveals common and distinct features of autoimmune inflammatory phenotypes
2019
ECCO '19 Copenhagen
Thursday, 28 February 2019, 8:13 AM
DOP27: Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn's Disease and chronic fatigue syndrome
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP27: The fibre fermentative capacity of the gut microbiota is diminished in children with Crohn’s Disease and it is independent of disease activity or treatment with exclusive enteral nutrition
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP27: Transanal minimally invasive surgery (TAMIS) – A noval approach for treatment of pouch failure
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP27: Transanal minimally invasive surgery (TAMIS) – A noval approach for treatment of pouch failure
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP28 Understanding the molecular mechanisms of anti-TNF treatment failure in patients with Crohn’s disease: A pilot serum proteomic analysis of the PANTS cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM